Executive Director, Head of Medical Affairs – Airways Disease

Company: RBW Consulting
Apply for the Executive Director, Head of Medical Affairs – Airways Disease
Location: Cambridge
Job Description:

Executive Director, Head of Medical Affairs – Airways Disease

3 days ago Be among the first 25 applicants

Get AI-powered advice on this job and more exclusive features.

Direct message the job poster from RBW Consulting

About the Role

A large global biotech near Cambridge is seeking a Global Medical Affairs Head – Respiratory to lead key respiratory/pulmonary assets towards commercialization. The company focuses on innovation and developing key prescription medicines for serious diseases.

Candidate Profile

  • Board-certified respiratory specialist with a passion for improving patient lives in asthma and respiratory conditions.
  • Background in academic clinical research in respiratory diseases.
  • Potential for career growth into industry leadership.

Responsibilities

  • Lead the Global Medical, Respiratory Biologics team.
  • Develop and oversee the Respiratory Biologics Medical Strategy, including lifecycle management.
  • Collaborate across global medical functions and with the Global Product Team (commercial, R&D, regulatory, biostatistics, etc.).
  • Design and execute Phase 3b/4 clinical trials and Real World Evidence studies.

Qualifications

  • MD with strong clinical research experience in Airways Disease.
  • Specialty training in pulmonology or respiratory medicine.
  • Strategic and medical leadership skills.
  • Experience leading large-scale medical initiatives in complex environments.
  • Strong relationships with global respiratory medicine leaders.

Additional Information

For more details about the company and compensation, click APPLY and submit an updated CV. This entry-level leadership role offers an opportunity to shape the future of respiratory biologics.

Job Details

  • Seniority level: Executive
  • Employment type: Full-time
  • Job function: Research

#J-18808-Ljbffr…

Posted: April 11th, 2026